285 related articles for article (PubMed ID: 17522343)
1. Antigen-specific suppression of experimental autoimmune encephalomyelitis by a novel bifunctional peptide inhibitor.
Kobayashi N; Kobayashi H; Gu L; Malefyt T; Siahaan TJ
J Pharmacol Exp Ther; 2007 Aug; 322(2):879-86. PubMed ID: 17522343
[TBL] [Abstract][Full Text] [Related]
2. Antigen-specific suppression of experimental autoimmune encephalomyelitis by a novel bifunctional peptide inhibitor: structure optimization and pharmacokinetics.
Ridwan R; Kiptoo P; Kobayashi N; Weir S; Hughes M; Williams T; Soegianto R; Siahaan TJ
J Pharmacol Exp Ther; 2010 Mar; 332(3):1136-45. PubMed ID: 20026673
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic and therapeutic suppression of experimental autoimmune encephalomyelitis by a novel bifunctional peptide inhibitor.
Kobayashi N; Kiptoo P; Kobayashi H; Ridwan R; Brocke S; Siahaan TJ
Clin Immunol; 2008 Oct; 129(1):69-79. PubMed ID: 18676182
[TBL] [Abstract][Full Text] [Related]
4. Controlling immune response and demyelination using highly potent bifunctional peptide inhibitors in the suppression of experimental autoimmune encephalomyelitis.
Kiptoo P; Büyüktimkin B; Badawi AH; Stewart J; Ridwan R; Siahaan TJ
Clin Exp Immunol; 2013 Apr; 172(1):23-36. PubMed ID: 23480182
[TBL] [Abstract][Full Text] [Related]
5. Suppression of MOG- and PLP-induced experimental autoimmune encephalomyelitis using a novel multivalent bifunctional peptide inhibitor.
Badawi AH; Siahaan TJ
J Neuroimmunol; 2013 Oct; 263(1-2):20-7. PubMed ID: 23911075
[TBL] [Abstract][Full Text] [Related]
6. Immune response to controlled release of immunomodulating peptides in a murine experimental autoimmune encephalomyelitis (EAE) model.
Zhao H; Kiptoo P; Williams TD; Siahaan TJ; Topp EM
J Control Release; 2010 Jan; 141(2):145-52. PubMed ID: 19748537
[TBL] [Abstract][Full Text] [Related]
7. Characterization of proteolipid protein-peptide-specific CD(4)(+) T cell of experimental allergic encephalomyelitis in Biozzi AB/H mice.
Peng Y; Liu CP
Chin Med J (Engl); 2002 Apr; 115(4):521-4. PubMed ID: 12133288
[TBL] [Abstract][Full Text] [Related]
8. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
[TBL] [Abstract][Full Text] [Related]
9. Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch.
Huan J; Subramanian S; Jones R; Rich C; Link J; Mooney J; Bourdette DN; Vandenbark AA; Burrows GG; Offner H
J Immunol; 2004 Apr; 172(7):4556-66. PubMed ID: 15034073
[TBL] [Abstract][Full Text] [Related]
10. Location of a new encephalitogenic epitope (residues 43 to 64) in proteolipid protein that induces relapsing experimental autoimmune encephalomyelitis in PL/J and (SJL x PL)F1 mice.
Whitham RH; Jones RE; Hashim GA; Hoy CM; Wang RY; Vandenbark AA; Offner H
J Immunol; 1991 Dec; 147(11):3803-8. PubMed ID: 1719089
[TBL] [Abstract][Full Text] [Related]
11. Eluding anaphylaxis allows peptide-specific prevention of the relapsing stage of experimental autoimmune encephalomyelitis.
Wegmann KW; Archie Bouwer HG; Whitham RH; Hinrichs DJ
J Neuroimmunol; 2014 Sep; 274(1-2):46-52. PubMed ID: 24997489
[TBL] [Abstract][Full Text] [Related]
12. Treatment of relapsing experimental autoimmune encephalomyelitis with T cell receptor peptides.
Whitham RH; Kotzin BL; Buenafe AC; Weinberg AD; Jones RE; Hashim GA; Hoy CM; Vandenbark AA; Offner H
J Neurosci Res; 1993 Jun; 35(2):115-28. PubMed ID: 7686583
[TBL] [Abstract][Full Text] [Related]
13. Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein.
Greer JM; Sobel RA; Sette A; Southwood S; Lees MB; Kuchroo VK
J Immunol; 1996 Jan; 156(1):371-9. PubMed ID: 8598487
[TBL] [Abstract][Full Text] [Related]
14. Immune responses of linear and cyclic PLP139-151 mutant peptides in SJL/J mice: peptides in their free state versus mannan conjugation.
Katsara M; Deraos S; Tselios TV; Pietersz G; Matsoukas J; Apostolopoulos V
Immunotherapy; 2014; 6(6):709-24. PubMed ID: 25186603
[TBL] [Abstract][Full Text] [Related]
15. Soluble mannosylated myelin peptide inhibits the encephalitogenicity of autoreactive T cells during experimental autoimmune encephalomyelitis.
Kel J; Oldenampsen J; Luca M; Drijfhout JW; Koning F; Nagelkerken L
Am J Pathol; 2007 Jan; 170(1):272-80. PubMed ID: 17200200
[TBL] [Abstract][Full Text] [Related]
16. Sequence 104-117 of myelin proteolipid protein is a cryptic encephalitogenic T cell determinant for SJL/J mice.
Tuohy VK; Thomas DM
J Neuroimmunol; 1995 Feb; 56(2):161-70. PubMed ID: 7532182
[TBL] [Abstract][Full Text] [Related]
17. IL-4, IL-10, IL-13, and TGF-beta from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis.
Young DA; Lowe LD; Booth SS; Whitters MJ; Nicholson L; Kuchroo VK; Collins M
J Immunol; 2000 Apr; 164(7):3563-72. PubMed ID: 10725711
[TBL] [Abstract][Full Text] [Related]
18. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread.
Takács K; Chandler P; Altmann DM
Eur J Immunol; 1997 Nov; 27(11):2927-34. PubMed ID: 9394820
[TBL] [Abstract][Full Text] [Related]
19. Induction of experimental allergic encephalomyelitis by myelin proteolipid-protein-specific T cell clones and synthetic peptides.
Kuchroo VK; Sobel RA; Yamamura T; Greenfield E; Dorf ME; Lees MB
Pathobiology; 1991; 59(5):305-12. PubMed ID: 1716908
[TBL] [Abstract][Full Text] [Related]
20. Male SJL mice do not relapse after induction of EAE with PLP 139-151.
Bebo BF; Vandenbark AA; Offner H
J Neurosci Res; 1996 Sep; 45(6):680-9. PubMed ID: 8892079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
